CTS Corp Q2 Sales Edge Up 1.1%, Net Income Dips 3.6%

TL;DR

**CTS is treading water with slight sales growth but a net income dip, so don't expect a breakout performance.**

AI Summary

CTS Corp reported a net sales increase of 1.1% to $150.2 million for the second quarter of 2025, up from $148.6 million in the prior-year quarter. For the six months ended June 30, 2025, net sales were $298.8 million, a slight decrease from $299.0 million in the same period of 2024. Net income for the second quarter of 2025 was $18.5 million, or $0.58 per diluted share, compared to $19.2 million, or $0.60 per diluted share, in the second quarter of 2024, representing a 3.6% decline. The company's strategic outlook includes continued investment in advanced materials and components, with a focus on the industrial and medical markets. Risks include fluctuations in foreign currency exchange rates, which impacted sales by $0.8 million in the second quarter of 2025. The company also incurred $0.5 million in building and equipment relocation costs during the first six months of 2025. Despite these challenges, CTS Corp maintains a strong balance sheet with total assets of $900.5 million as of June 30, 2025.

Why It Matters

CTS Corp's modest sales growth and slight net income dip signal a challenging but stable environment for investors, suggesting that while the company is not experiencing rapid expansion, it is maintaining its market position. For employees, the continued investment in advanced materials indicates job stability and potential for innovation within the company. Customers can expect continued product development, particularly in industrial and medical sectors, which could lead to more advanced solutions. In the broader market, CTS's performance reflects the current demand for electronic components and sensors, highlighting the competitive pressures and the importance of strategic investments in high-growth areas.

Risk Assessment

Risk Level: medium — The risk level is medium due to the slight decline in net income by 3.6% to $18.5 million in Q2 2025 compared to Q2 2024, and the impact of foreign currency exchange rates, which reduced sales by $0.8 million. Additionally, the company incurred $0.5 million in building and equipment relocation costs, indicating ongoing operational adjustments that could affect profitability.

Analyst Insight

Investors should hold CTS stock, monitoring future reports for sustained revenue growth and improved net income margins. Focus on the company's strategic investments in industrial and medical markets, as these segments could drive future profitability and offset currency headwinds.

Financial Highlights

revenue

$150.2M

total Assets

$900.5M

net Income

$18.5M

eps

$0.58

revenue Growth

+1.1%

Revenue Breakdown

Key Numbers

• $150.2M — Q2 2025 Net Sales (Increased by 1.1% from Q2 2024)
• $18.5M — Q2 2025 Net Income (Decreased by 3.6% from Q2 2024)
• $0.58 — Q2 2025 Diluted EPS (Decreased from $0.60 in Q2 2024)
• 1.1% — Q2 2025 Net Sales Growth (Year-over-year increase)
• 3.6% — Q2 2025 Net Income Decline (Year-over-year decrease)
• $0.8M — Foreign Currency Impact (Negative impact on Q2 2025 sales)
• $0.5M — Relocation Costs (Incurred in the first six months of 2025)
• $900.5M — Total Assets (As of June 30, 2025)

Key Players & Entities

• CTS CORP (company) — filer of the 10-Q
• $150.2 million (dollar_amount) — net sales for Q2 2025
• $148.6 million (dollar_amount) — net sales for Q2 2024
• $18.5 million (dollar_amount) — net income for Q2 2025
• $19.2 million (dollar_amount) — net income for Q2 2024
• $0.58 (dollar_amount) — diluted EPS for Q2 2025
• $0.60 (dollar_amount) — diluted EPS for Q2 2024
• $0.8 million (dollar_amount) — negative impact from foreign currency exchange rates on Q2 2025 sales
• $0.5 million (dollar_amount) — building and equipment relocation costs for the first six months of 2025
• $900.5 million (dollar_amount) — total assets as of June 30, 2025

FAQ

Risk Factors

• Foreign Currency Fluctuations [medium — financial]: Fluctuations in foreign currency exchange rates negatively impacted sales by $0.8 million in the second quarter of 2025. This indicates a sensitivity to global economic conditions and currency movements, which can affect reported revenues.
• Relocation Costs [low — operational]: The company incurred $0.5 million in building and equipment relocation costs during the first six months of 2025. These one-time expenses can temporarily depress profitability and operational efficiency.

Industry Context

CTS Corp operates in the electronic components manufacturing sector, specifically focusing on printed circuit boards. The industry is characterized by rapid technological advancements, global supply chain complexities, and demand driven by sectors like automotive, industrial, and medical. Competition is often intense, requiring continuous innovation and cost management.

Regulatory Implications

As a manufacturer of electronic components, CTS Corp is subject to various regulations related to product safety, environmental standards, and international trade. Compliance with these regulations is crucial to avoid penalties and maintain market access. Changes in trade policies or tariffs could also impact its global operations and profitability.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]

Glossary

Diluted EPS

Earnings per share calculated by dividing net income by the total number of diluted shares outstanding. It represents the earnings attributable to each share of common stock, assuming all convertible securities and stock options were exercised. (Key metric for profitability per share, showing a slight decrease to $0.58 in Q2 2025.)

Foreign Currency Impact

The effect of changes in exchange rates on the value of a company's financial transactions and reported results when operating in multiple currencies. (Negatively impacted Q2 2025 sales by $0.8 million, highlighting a financial risk.)

Building and Equipment Relocation

Costs associated with moving physical assets, such as buildings and machinery, from one location to another. (Incurred $0.5 million in the first six months of 2025, impacting short-term profitability.)

Year-Over-Year Comparison

Compared to the prior year, CTS Corp reported a modest 1.1% increase in net sales for Q2 2025 to $150.2 million, but net income saw a 3.6% decline to $18.5 million, resulting in lower diluted EPS of $0.58. While total assets remain strong at $900.5 million, the company faced headwinds from $0.8 million in negative foreign currency impact and $0.5 million in relocation costs during the first six months of 2025, which may have contributed to the margin compression.

From the Filing

0000950170-25-098225.txt : 20250724 0000950170-25-098225.hdr.sgml : 20250724 20250724120045 ACCESSION NUMBER: 0000950170-25-098225 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 102 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250724 DATE AS OF CHANGE: 20250724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CTS CORP CENTRAL INDEX KEY: 0000026058 STANDARD INDUSTRIAL CLASSIFICATION: PRINTED CIRCUIT BOARDS [3672] ORGANIZATION NAME: 04 Manufacturing EIN: 350225010 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-04639 FILM NUMBER: 251145561 BUSINESS ADDRESS: STREET 1: 4925 INDIANA AVENUE CITY: LISLE STATE: IL ZIP: 60532 BUSINESS PHONE: 6305778800 MAIL ADDRESS: STREET 1: 4925 INDIANA AVENUE CITY: LISLE STATE: IL ZIP: 60532 10-Q 1 cts-20250630.htm 10-Q 10-Q false --12-31 Q2 0000026058 http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#Revenues http://fasb.org/us-gaap/2024#Revenues http://fasb.org/us-gaap/2024#Revenues http://fasb.org/us-gaap/2024#Revenues http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#InterestExpenseNonoperating http://fasb.org/us-gaap/2024#InterestExpenseNonoperating http://fasb.org/us-gaap/2024#InterestExpenseNonoperating http://fasb.org/us-gaap/2024#InterestExpenseNonoperating http://fasb.org/us-gaap/2024#InterestExpenseNonoperating http://fasb.org/us-gaap/2024#InterestExpenseNonoperating http://fasb.org/us-gaap/2024#InterestExpenseNonoperating http://fasb.org/us-gaap/2024#InterestExpenseNonoperating http://ctscorp.com/20250630#ChairPresidentAndChiefExecutiveOfficerMember 0000026058 us-gaap:MachineryAndEquipmentMember 2024-12-31 0000026058 cts:TwoThousandNinePlanMember 2025-06-30 0000026058 us-gaap:BuildingAndBuildingImprovementsMember 2024-12-31 0000026058 us-gaap:CommonStockMember 2024-12-31 0000026058 us-gaap:CommonStockMember 2025-03-31 0000026058 cts:BuildingAndEquipmentRelocationMember 2025-01-01 2025-06-30 0000026058 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember us-gaap:ForeignExchangeContractMember 2025-01-01 2025-06-30 0000026058 srt:ScenarioPreviouslyReportedMember 2024-07-01 2024-09-30 0000026058 cts:ForeignCurrencyDenominatedDebtMember us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2025-01-01 2025-06-30 0000026058 us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0000026058 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2025-01-01 2025-06-30 0000026058 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-06-30 0000026058 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueInputsLevel2Member us-gaap:CashFlowHedgingMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForwardContractsMember 2024-12-31 0000026058 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000026058 cts:ContingentConsiderationMember 2025-06-30 0000026058 us-gaap:CrossCurrencyInterestRateContractMember 2025-06-30 0000026058 us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-06-30 0000026058 2025-01-01 2025-03-31 0000026058 cts:IndustrialMember 2025-0